Health News

Notifications

Access Denied
It is available in , , and mg strengths, mainly to counteract common gastrointestinal side effects, as well as to increase compliance by reducing pill burden. A case of comparing apples and pears? Kids, teen, college student mental health problems on the rise A new WHO report adds to a wave of studies about teen mental health problems. In healthy individuals, this slight excess is cleared by other mechanisms including uptake by unimpaired kidneys , and no significant elevation in blood levels of lactate occurs. New Preparations and Nonglycemic Benefits".

Top Health Stories

Questions & Answers A-Z

Metformin is primarily used for type 2 diabetes, but is increasingly being used in polycystic ovary syndrome due to the linkage between these two conditions. The American Diabetes Association and the American College of Physicians each recommend metformin as a first-line agent to treat type 2 diabetes.

The UK Prospective Diabetes Study, a large clinical trial performed in s, provided evidence that metformin reduced the rate of adverse cardiovascular outcomes in overweight patients with type 2 diabetes relative to other antihyperglycemic agents. Treatment guidelines for major professional associations including the European Association for the Study of Diabetes , the European Society for Cardiology and the American Diabetes Association , now describe evidence for the cardiovascular benefits of metformin as equivocal.

In , the American College of Physicians 's guidelines were updated to recognize metformin as the first-line treatment for type-2 diabetes.

These guidelines supersede earlier reviews. For example, a review found tentative evidence that people treated with sulfonylureas had a higher risk of severe low blood sugar events RR 5. There was not enough data available at that time to determine the relative risk of death or of death from heart disease.

Metformin has little or no effect on body weight in type 2 diabetes compared with placebo , [27] in contrast to sulfonylureas which are associated with weight gain. Metformin treatment of people at a prediabetes stage of risk for type 2 diabetes may decrease their chances of developing the disease, although intensive physical exercise and dieting work significantly better for this purpose.

In a large U. Among younger people with a higher body mass index , lifestyle modification was no more effective than metformin, and for older individuals with a lower body mass index, metformin was no better than placebo in preventing diabetes.

Antidiabetic therapy has been proposed as a treatment for polycystic ovary syndrome PCOS , a condition frequently associated with insulin resistance, since the late s.

UK and international clinical practice guidelines do not recommend metformin as a first-line treatment [43] or do not recommend it at all, except for women with glucose intolerance. Metformin treatment decreases the risk of developing type 2 diabetes mellitus in women with PCOS who exhibited impaired glucose tolerance IGT at baseline. Metformin or clomiphene are both first line treatments for infertility in women with PCOS. Four positive studies of metformin were in women not responding to clomifene, while the population in the negative studies was drug-naive or uncontrolled for the previous treatment.

Metformin should be used as a second-line medication if clomifene treatment fails. The use of metformin during all parts of pregnancy is controversial. Metformin use among women with PCOS before they are pregnant does not appear to reduce abortion risk.

Several observational studies and randomized, controlled trials found metformin to be as effective and safe as insulin for the management of gestational diabetes. Nonetheless, several concerns were raised and evidence on the long-term safety of metformin for both mother and child is lacking. Metformin is safe in pregnancy and women with gestational diabetes treated with metformin have less weight gain during pregnancy than those treated with insulin.

Metformin appears to be safe and effective in counteracting the weight gain caused by the antipsychotic medications olanzapine and clozapine. Metformin may reduce the insulin requirement in type 1 diabetes.

According to the prescribing information , heart failure in particular, unstable or acute congestive heart failure increases the risk of lactic acidosis with metformin. Metformin is recommended to be temporarily discontinued before any radiographic study involving iodinated contrast agents, such as a contrast-enhanced CT scan or angiogram , as the contrast dye may temporarily impair kidney function, indirectly leading to lactic acidosis by causing retention of metformin in the body.

The most common adverse effect of metformin is gastrointestinal irritation, including diarrhea , cramps, nausea, vomiting, and increased flatulence ; metformin is more commonly associated with gastrointestinal side effects than most other antidiabetic medications. Metformin has also been reported to decrease the blood levels of thyroid-stimulating hormone in people with hypothyroidism. In a clinical trial of subjects, Gastrointestinal upset can cause severe discomfort; it is most common when metformin is first administered, or when the dose is increased.

The discomfort can often be avoided by beginning at a low dose 1. Long-term use of metformin has been associated with increased homocysteine levels [71] and malabsorption of vitamin B The most serious potential adverse effect of biguanide use is metformin-associated lactic acidosis MALA.

Though the incidence for MALA is about nine per , person-years, [76] this is similar to the background incidence of lactic acidosis in the general population. A systematic review concluded no data exists to definitively link metformin to lactic acidosis.

Phenformin , another biguanide, was withdrawn from the market because of an increased risk of lactic acidosis rate of per , patient-years. Lactate uptake by the liver is diminished with metformin administration because lactate is a substrate for hepatic gluconeogenesis , a process that metformin inhibits. In healthy individuals, this slight excess is cleared by other mechanisms including uptake by unimpaired kidneys , and no significant elevation in blood levels of lactate occurs.

Because metformin decreases liver uptake of lactate, any condition that may precipitate lactic acidosis is a contraindication. Metformin has been suggested as increasing production of lactate in the large intestine, which could potentially contribute to lactic acidosis in those with risk factors.

Lactic acidosis is initially treated with sodium bicarbonate , although high doses are not recommended, as this may increase intracellular acidosis. A review of metformin overdoses reported to poison control centers over a five-year period found serious adverse events were rare, though the elderly appeared to be at greater risk. The most common symptoms following overdose include vomiting, diarrhea , abdominal pain, tachycardia , drowsiness, and, rarely, hypoglycemia or hyperglycemia. Extracorporeal treatments are recommended in severe overdoses.

Metformin may be quantified in blood, plasma, or serum to monitor therapy, confirm a diagnosis of poisoning, or assist in a forensic death investigation. Chromatographic techniques are commonly employed. The H 2 -receptor antagonist cimetidine causes an increase in the plasma concentration of metformin by reducing clearance of metformin by the kidneys; [91] both metformin and cimetidine are cleared from the body by tubular secretion , and both, particularly the cationic positively charged form of cimetidine, may compete for the same transport mechanism.

Metformin also interacts with anticholinergic medications, due to their effect on gastric motility. Anticholinergic drugs reduce gastric motility, prolonging the time drugs spend in the gastrointestinal tract. This impairment may lead to more metformin being absorbed than without the presence of an anticholinergic drug, thereby increasing the concentration of metformin in the plasma and increasing the risk for adverse effects.

Metformin's main effect is to decrease liver glucose production. Metformin decreases high blood sugar , primarily by suppressing liver glucose production hepatic gluconeogenesis. Multiple potential mechanisms of action have been proposed, including; inhibition of the mitochondrial respiratory chain complex I , activation of AMP-activated protein kinase AMPK , inhibition of glucagon-induced elevation of cyclic adenosine monophosphate cAMP with reduced activation of protein kinase A PKA , inhibition of mitochondrial glycerophosphate dehydrogenase , and an effect on gut microbiota.

Activation of AMPK was required for metformin's inhibitory effect on liver glucose production. In addition to suppressing hepatic glucose production, metformin increases insulin sensitivity, enhances peripheral glucose uptake by inducing the phosphorylation of GLUT4 enhancer factor , decreases insulin-induced suppression of fatty acid oxidation , [] and decreases absorption of glucose from the gastrointestinal tract.

Increased peripheral use of glucose may be due to improved insulin binding to insulin receptors. AMPK probably also plays a role in increased peripheral insulin sensitivity, as metformin administration increases AMPK activity in skeletal muscle. The usual synthesis of metformin, originally described in , involves the one-pot reaction of dimethylamine hydrochloride and 2-cyanoguanidine over heat. According to the procedure described in the Aron patent, [] and the Pharmaceutical Manufacturing Encyclopedia , [] equimolar amounts of dimethylamine and 2-cyanoguanidine are dissolved in toluene with cooling to make a concentrated solution, and an equimolar amount of hydrogen chloride is slowly added.

Steady state is usually reached in one or two days. Metformin has acid dissociation constant values pKa of 2. The metformin pKa values make metformin a stronger base than most other basic medications with less than 0. Furthermore, the lipid solubility of the nonionized species is slight as shown by its low logP value log 10 of the distribution coefficient of the nonionized form between octanol and water of These chemical parameters indicate low lipophilicity and, consequently, rapid passive diffusion of metformin through cell membranes is unlikely.

As a result of its low lipid solubility it requires the transporter SLC22A1 in order for it to enter cells. Your doctor can determine the cause of liver distress with the help of blood tests and a comprehensive health history. Loss of appetite, nausea and vomiting, diarrhea and stomach pain could be the flu, but if your liver enzymes are elevated it could be a case of hepatitis A. The hepatitis A virus also typically causes jaundice.

It is spread by fecal-oral contamination, a result of poor bathroom hygiene or food contamination. The virus is shed in the stool of infected persons. Hepatitis A is a self-limiting disorder; you may need only rest and plenty of fluids to get over it. Infection with the hepatitis B or C viruses may cause chronic illness and damage to the liver that occurs over time. The Illinois Department of Public Health reports that hepatitis C is spread by blood, putting health care workers, IV drug users and those who received blood transfusions prior to at highest risk.

Hepatitis B can be prevented by vaccines. A healthy liver aids the digestion of fats and proteins, regulates sex hormones, breaks down toxins in the bloodstream and removes excess red blood cells. Chronic alcohol abuse taxes the liver, causing accumulation of fatty deposits, which become inflamed, leading to alcoholic hepatitis.

The American Liver Foundation states that 35 percent of heavy drinkers develop this condition. People benefit from just 13 minutes of exercise, study finds. Genetically modified mosquitoes could eradicate malaria.

Amazing advancements against cancer, but not everyone benefits. FDA calls e-cigarettes 'an epidemic' among minors. Barbara Feder Ostrov on her Prudence Hall story. How one mom changed an organ transplant policy to save her dying daughter. Can you give up added sugar for a whole month? Doctors providing opioids without proper documentation: Olivia Newton-John reveals that her breast cancer has returned. Why Jennifer Garner's nutritionist starts every day with a smoothie.

Latest Health Headlines Sep Family of Smart's kidnapper won't take her in: Niece Days before het release from prison, fears about whether a woman who helped in the kidnapping of then-teenager Elizabeth Smart remains a threat and Infection, electrocution and injury: Florence's floodwaters may carry hidden dangers Floodwaters carry hidden risks that cause electrocution, injury and infection. Kids, teen, college student mental health problems on the rise A new WHO report adds to a wave of studies about teen mental health problems.

Las Vegas shooting survivors, health care providers reunite Survivors of the mass shooting in Las Vegas have reunited with the doctors and nurses who cared for them at an area hospital after the massacre.

New US survey shows some progress against opioid crisis A U. Lawsuit aims to block Trump 'short-term' health plans Patient advocates sue to block Trump administration's 'short-term' health insurance plans. FDA plans meeting to discuss safety data on breast implants U. Zimbabwe's government criticized over cholera outbreak Zimbabwe's government criticized over cholera outbreak that has killed 25, spread from capital.

Some Bob Evans sausage links recalled, may contain plastic The Agriculture Department says Bob Evans Farms is recalling nearly 47, pounds of pork sausage links because they might contain pieces of plastic.

Navigation menu